Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model
- PMID: 28779028
- DOI: 10.1042/CS20171006
Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model
Abstract
Formyl peptide receptor 2/lipoxin A4 (LXA4) receptor (Fpr2/ALX) co-ordinates the transition from inflammation to resolution during acute infection by binding to distinct ligands including serum amyloid A (SAA) and Resolvin D1 (RvD1). Here, we evaluated the proresolving actions of aspirin-triggered RvD1 (AT-RvD1) in an acute coinfection pneumonia model. Coinfection with Streptococcus pneumoniae and influenza A virus (IAV) markedly increased pneumococcal lung load and neutrophilic inflammation during the resolution phase. Fpr2/ALX transcript levels were increased in the lungs of coinfected mice, and immunohistochemistry identified prominent Fpr2/ALX immunoreactivity in bronchial epithelial cells and macrophages. Levels of circulating and lung SAA were also highly increased in coinfected mice. Therapeutic treatment with exogenous AT-RvD1 during the acute phase of infection (day 4-6 post-pneumococcal inoculation) significantly reduced the pneumococcal load. AT-RvD1 also significantly reduced neutrophil elastase (NE) activity and restored total antimicrobial activity in bronchoalveolar lavage (BAL) fluid (BALF) of coinfected mice. Pneumonia severity, as measured by quantitating parenchymal inflammation or alveolitis was significantly reduced with AT-RvD1 treatment, which also reduced the number of infiltrating lung neutrophils and monocytes/macrophages as assessed by flow cytometry. The reduction in distal lung inflammation in AT-RvD1-treated mice was not associated with a significant reduction in inflammatory and chemokine mediators. In summary, we demonstrate that in the coinfection setting, SAA levels were persistently increased and exogenous AT-RvD1 facilitated more rapid clearance of pneumococci in the lungs, while concurrently reducing the severity of pneumonia by limiting excessive leukocyte chemotaxis from the infected bronchioles to distal areas of the lungs.
Keywords: Serum amyloid A; co-infection; formyl peptide receptor-2; pneumonia; resolvin D1.
© 2017 The Author(s).
Similar articles
-
Increased hypothalamic microglial activation after viral-induced pneumococcal lung infection is associated with excess serum amyloid A production.J Neuroinflammation. 2018 Jul 6;15(1):200. doi: 10.1186/s12974-018-1234-1. J Neuroinflammation. 2018. PMID: 29980196 Free PMC article.
-
Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice.Am J Physiol Lung Cell Mol Physiol. 2021 Jun 1;320(6):L1085-L1092. doi: 10.1152/ajplung.00046.2021. Epub 2021 Apr 6. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 33822656 Free PMC article.
-
15-Epi-LXA4 and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation.Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7971-7980. doi: 10.1073/pnas.1920193117. Epub 2020 Mar 23. Proc Natl Acad Sci U S A. 2020. PMID: 32205444 Free PMC article.
-
Resolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise Review.Front Immunol. 2018 Oct 16;9:2345. doi: 10.3389/fimmu.2018.02345. eCollection 2018. Front Immunol. 2018. PMID: 30459754 Free PMC article. Review.
-
VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis.Prostaglandins Other Lipid Mediat. 2019 Feb;140:18-25. doi: 10.1016/j.prostaglandins.2018.12.001. Epub 2018 Dec 4. Prostaglandins Other Lipid Mediat. 2019. PMID: 30529189 Free PMC article. Review.
Cited by
-
G-CSFR antagonism reduces neutrophilic inflammation during pneumococcal and influenza respiratory infections without compromising clearance.Sci Rep. 2019 Nov 27;9(1):17732. doi: 10.1038/s41598-019-54053-w. Sci Rep. 2019. PMID: 31776393 Free PMC article.
-
A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis.Front Immunol. 2018 Apr 23;9:798. doi: 10.3389/fimmu.2018.00798. eCollection 2018. Front Immunol. 2018. PMID: 29740435 Free PMC article.
-
Targeting the human βc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure.Respirology. 2022 Aug;27(8):617-629. doi: 10.1111/resp.14297. Epub 2022 May 22. Respirology. 2022. PMID: 35599245 Free PMC article.
-
Resolvin T-series reduce neutrophil extracellular traps.Blood. 2022 Feb 24;139(8):1222-1233. doi: 10.1182/blood.2021013422. Blood. 2022. PMID: 34814186 Free PMC article.
-
Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediators.Exp Biol Med (Maywood). 2023 Oct;248(19):1635-1644. doi: 10.1177/15353702231199082. Epub 2023 Oct 14. Exp Biol Med (Maywood). 2023. PMID: 37837390 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources